
Indoco Remedies Limited has informed the Exchange regarding a press release dated September 19, 2025, titled "USFDA successfully completes inspection at Indoco s API manufacturing facility at Patalganga with zero observations".
Filed with NSE ·

Indoco Remedies Limited has informed the Exchange regarding a press release dated September 19, 2025, titled "USFDA successfully completes inspection at Indoco s API manufacturing facility at Patalganga with zero observations".
6ix hasn’t read this filing yet.
Indoco Remedies Limited on 6ix
Follow Indoco Remedies into a list and get an email when it puts out news.
Follow Indoco Remedies